Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists
Copyright © 2014 Elsevier Ltd. All rights reserved..
2-(3-(Naphthalen-2-yl)propanamido)cyclohex-1-enecarboxylic acid and its 6-hydroxynaphthalen-2-yl analogue are well-known hydroxyl-carboxylic acid (HCA) receptor HCA2 agonists. A series of novel aryl derivatives of 2-amidocyclohex-1-ene carboxylic acid that contained rigidity elements, such as an E-double bond, triple bond, and trans or cis-substituted cyclopropane rings, instead of the saturated ethane linker in the amide part of the molecules were designed and synthesized, and the derivatives' potency for the activation of HCA1, HCA2, and HCA3 receptors by 3'-5'-cyclic adenosine monophosphate (cAMP) assay were evaluated. The SAR studies revealed that the rigidifying of appropriate molecules enabled modulation of the potency and selectivity of the HCA2 receptor activation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Bioorganic & medicinal chemistry - 22(2014), 14 vom: 15. Juli, Seite 3654-69 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bobileva, Olga [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 28.12.2014 Date Revised 11.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bmc.2014.05.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM238586073 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM238586073 | ||
| 003 | DE-627 | ||
| 005 | 20231224114121.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmc.2014.05.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0795.xml |
| 035 | |a (DE-627)NLM238586073 | ||
| 035 | |a (NLM)24864041 | ||
| 035 | |a (PII)S0968-0896(14)00360-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bobileva, Olga |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.12.2014 | ||
| 500 | |a Date Revised 11.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2014 Elsevier Ltd. All rights reserved. | ||
| 520 | |a 2-(3-(Naphthalen-2-yl)propanamido)cyclohex-1-enecarboxylic acid and its 6-hydroxynaphthalen-2-yl analogue are well-known hydroxyl-carboxylic acid (HCA) receptor HCA2 agonists. A series of novel aryl derivatives of 2-amidocyclohex-1-ene carboxylic acid that contained rigidity elements, such as an E-double bond, triple bond, and trans or cis-substituted cyclopropane rings, instead of the saturated ethane linker in the amide part of the molecules were designed and synthesized, and the derivatives' potency for the activation of HCA1, HCA2, and HCA3 receptors by 3'-5'-cyclic adenosine monophosphate (cAMP) assay were evaluated. The SAR studies revealed that the rigidifying of appropriate molecules enabled modulation of the potency and selectivity of the HCA2 receptor activation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 2-Acrylamidocyclohex-1-ene | |
| 650 | 4 | |a Agonist | |
| 650 | 4 | |a Dyslipidemia | |
| 650 | 4 | |a GPR109A | |
| 650 | 4 | |a HCA2 | |
| 650 | 4 | |a Niacin | |
| 650 | 4 | |a cAMP | |
| 650 | 7 | |a Acrylamides |2 NLM | |
| 650 | 7 | |a Cyclohexanecarboxylic Acids |2 NLM | |
| 650 | 7 | |a HCAR1 protein, human |2 NLM | |
| 650 | 7 | |a HCAR2 protein, human |2 NLM | |
| 650 | 7 | |a HCAR3 protein, human |2 NLM | |
| 650 | 7 | |a Receptors, G-Protein-Coupled |2 NLM | |
| 650 | 7 | |a Receptors, Nicotinic |2 NLM | |
| 700 | 1 | |a Bokaldere, Rasma |e verfasserin |4 aut | |
| 700 | 1 | |a Gailite, Vija |e verfasserin |4 aut | |
| 700 | 1 | |a Kaula, Ilze |e verfasserin |4 aut | |
| 700 | 1 | |a Ikaunieks, Martins |e verfasserin |4 aut | |
| 700 | 1 | |a Duburs, Gunars |e verfasserin |4 aut | |
| 700 | 1 | |a Petrovska, Ramona |e verfasserin |4 aut | |
| 700 | 1 | |a Mandrika, Ilona |e verfasserin |4 aut | |
| 700 | 1 | |a Klovins, Janis |e verfasserin |4 aut | |
| 700 | 1 | |a Loza, Einars |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d 1994 |g 22(2014), 14 vom: 15. Juli, Seite 3654-69 |w (DE-627)NLM074978543 |x 1464-3391 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2014 |g number:14 |g day:15 |g month:07 |g pages:3654-69 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bmc.2014.05.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2014 |e 14 |b 15 |c 07 |h 3654-69 | ||